Center for Outcomes Research, Real World Evidence and Epidemiology (CORE) Intern
Genmab is an international biotechnology company dedicated to improving the lives of patients through innovative antibody therapeutics. The Center for Outcomes Research, Real World Evidence and Epidemiology (CORE) Intern will work on strategy and projects related to an oncology product approaching launch, gaining exposure to HEOR, RWE, and Medical Affairs teams. Responsibilities Conduct literature search/review re: unmet needs, treatment guidelines, impact of treatment on clinical, economic, patient reported outcomes Lead HEOR research projects providing input on study design, data analysis and results Develop/Present (power point slides) on research-related topics to an extended or cross-functional team Assist in preparations for medical planning and launch planning as appropriate Assist in preparations for early scientific advice as appropriate Skills PhD student who has completed course work towards a PhD degree in Epidemiology, Economics, Public Health, Pharmaceutical Policy or a closely related area Strong analytical skills with the ability to translate key insights into strategy / tactics Organized and detail-oriented Excellent time management, verbal & written communication skills Proficiency in SAS/R Programming and experience in working with claims and electronic health record datasets Experience in oncology therapeutic area Experience using AI tools for HEOR analyses Company Overview Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. It was founded in 1999, and is headquartered in Copenhagen, Hovedstaden, DNK, with a workforce of 1001-5000 employees. Its website is